Profiel
Eric Victory is currently Director at Licensing Executives Society USA & Canada, Inc. and Vice President-Corporate Development at Aurinia Pharmaceuticals, Inc. since 2024.
Formerly, Mr. Victory was Vice President at AstraZeneca PLC from 2002 to 2020.
Education includes undergraduate studies at Stanford University and an MBA from Northwestern University.
Actieve functies van Eric Victory
| Bedrijven | Functie | Begin |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-11-2024 |
Licensing Executives Society USA & Canada, Inc.
Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Directeur/Bestuurslid | - |
Eerdere bekende functies van Eric Victory
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2020 |
Opleiding van Eric Victory
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Licensing Executives Society USA & Canada, Inc.
Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Commercial Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
















